stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. BGLC
    stockgist
    HomeTop MoversCompaniesConcepts
    BGLC logo

    BioNexus Gene Lab Corp.

    BGLC
    NASDAQ
    Healthcare
    Medical - Diagnostics & Research
    Kuala Lumpur, MY30 employeesbionexusgenelab.com
    $2.27
    -0.00(-0.08%)

    Mkt Cap $4M

    $1.94
    $11.14

    52-Week Range

    At A Glance

    1

    BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn.

    2

    Most recently: , including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed inco (2026-02-23).

    $4M

    Market Cap

    $9M

    Revenue

    -$2M

    Net Income

    Employees30
    Fundamentals

    How The Business Makes Money

    BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

    Industry Medical - Diagnostics & Research
    Activity

    What Changed Recently

    Other Event
    Feb 22, 2026

    , including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed inco

    Other Event
    Feb 2, 2026

    Other Events On January 28, 2026, BioNexus Gene Lab Corp. (the “Company”) issued a press release announcing the formal commencement of its 2026 regional deploym

    Company Profile
    CIK0001737523
    ISINUS0906283066
    CUSIP090628306
    Phone60 1 2212 6512
    AddressTower B, Vertical Business Suite, Kuala Lumpur, 59200, MY
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice